Your browser doesn't support javascript.
Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada.
Kuenzig, M Ellen; Widdifield, Jessica; Bernatsky, Sasha; Kaplan, Gilaad G; Benchimol, Eric I.
  • Kuenzig ME; SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada.
  • Widdifield J; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Sunnybrook Research Institute, Holland Bone & Joint Program, Toronto, ON, Canada; ICES, Toronto, ON, Canada.
  • Bernatsky S; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada.
  • Kaplan GG; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Benchimol EI; SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation,
Lancet Gastroenterol Hepatol ; 7(4): 288-289, 2022 04.
Article in English | MEDLINE | ID: covidwho-1704682

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Lancet Gastroenterol Hepatol Year: 2022 Document Type: Article Affiliation country: S2468-1253(22)00054-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Lancet Gastroenterol Hepatol Year: 2022 Document Type: Article Affiliation country: S2468-1253(22)00054-1